Clinical Trials Unit

Led by Associate Professor Meera Agar, Ingham Institute’s Clinical Trials Unit is designed to foster close working relationships between clinicians, pharmacy, pathology, finance, human resources and the executive team to enhance clinical trials capability.

Clinical trials are essential to confirm whether medicines are safe and effective to introduce as new treatments for a particular disease or condition and may also be used to determine whether an existing medicine can be safely and effectively for other diseases. Results from these trials can lead to the development of new pharmaceutical drugs and treatments helping to improve the health and wellbeing of Australians living with critical diseases.

The Institute’s Clinical Trials group prides itself in producing high quality data in accordance with regulatory requirements to deliver trials in a timely and cost-competitive manner with streamlined research and ethics.

The Ingham Institute’s Clinical Trials Group specialises in the following clinical areas and is expanding rapidly:

  • Gastroenterology
  • Haematology
  • Injury & Rehabilitation
  • Intensive Care (ICU)
  • Neurology
  • Oncology
  • Palliative Care
  • Renal Diseases
  • Respiratory and Sleep Medicine

As a result of the Ingham Institute’s partnerships with the South Western Sydney Local Health District, the University of Western Sydney and UNSW Australia, the group can facilitate unique collaborations with hospital based principal investigators and key university researchers to build capacity for early phase clinical research.

A Clinical Trials Scholarship has also been jointly sponsored by SWSLHD and the Ingham Institute which assists in capacity building in clinical trials expertise.

Click here for a copy of our Clinical Trials Prospectus.

Group Leader:
A/Professor Meera Agar
View Profile